1-4 of 4
Luis G. Paz-Ares
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

Helena A. Yu, Luis G. Paz-Ares, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Sameera R. Wijayawardana, Ling Gao, Rebecca R. Hozak, Bo H. Chao, David Planchard
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (4): 992–1002.
https://doi.org/10.1158/1078-0432.CCR-20-1690
Published: 15 February 2021
View article titled, Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive <em>EGFR</em>-mutant Non–small Cell Lung Cancer
Open the PDF for Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive <em>EGFR</em>-mutant Non–small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Edward S. Kim, Karen Kelly, Luis G. Paz-Ares, Pilar Garrido, Shadia Jalal, Daruka Mahadevan, Martin Gutierrez, Mariano Provencio, Eric Schaefer, Monte Shaheen, Erica L. Johnston, P. Kellie Turner, Siva Rama Prasad Kambhampati, Richard Beckmann, Anwar Hossain, William J. John, Jonathan W. Goldman
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (22): 5543–5551.
https://doi.org/10.1158/1078-0432.CCR-18-0651
Published: 15 November 2018
View article titled, Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study
Open the PDF for Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study in another window
Includes: Supplementary data
Journal Articles

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Antonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, Jason Christiansen, Yu-Fen Wang, Mary L. Hixon, Jennifer Reynolds, Sandra McDonald, Agnes Ang, David L. Rimm, Corey J. Langer, Johnetta Blakely, Linda Garland, Luis G. Paz-Ares, Daniel D. Karp, Adrian V. Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4654–4665.
https://doi.org/10.1158/1078-0432.CCR-10-0089
Published: 14 September 2010
View article titled, Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition
Open the PDF for Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition in another window
Journal Articles

Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid

Nicolas J. Dickgreber, Jens Benn Sorensen, Luis G. Paz-Ares, Tine Kjestrup Schytte, Jane E. Latz, Karen B. Schneck, Zheng Yuan, José Miguel Sanchez-Torres
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2872–2880.
https://doi.org/10.1158/1078-0432.CCR-09-3324
Published: 13 May 2010
View article titled, Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
Open the PDF for Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid in another window